IL1B and myelodysplastic syndrome: An ex vivo study revealed that the IL-1β-neutralizing antibody canakinumab markedly enhanced the colony-forming activity of HSPCs when cocultured with BM monocytes from SF3B1-mutated LR-MDS [255].